164 related articles for article (PubMed ID: 21212295)
21. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.
Kovalova N; Manzan M; Crawford R; Kaminski N
Toxicol Appl Pharmacol; 2016 Oct; 309():15-23. PubMed ID: 27535091
[TBL] [Abstract][Full Text] [Related]
22. Preliminary research on DNA methylation changes during murine palatogenesis induced by TCDD.
Wang C; Yuan XG; Liu CP; Zhai SN; Zhang DW; Fu YX
J Craniomaxillofac Surg; 2017 May; 45(5):678-684. PubMed ID: 28336320
[TBL] [Abstract][Full Text] [Related]
23. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
24. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on interleukin-4-mediated mechanisms of immunity.
Karras JG; Conrad DH; Holsapple MP
Toxicol Lett; 1995 Jan; 75(1-3):225-33. PubMed ID: 7863531
[TBL] [Abstract][Full Text] [Related]
25. Chronic TCDD exposure results in the dysregulation of gene expression in splenic B-lymphocytes and in the impairments in T-cell and B-cell differentiation in mouse model.
Feng Y; Tian J; Krylova I; Xu T; Xie HQ; Guo TL; Zhao B
J Environ Sci (China); 2016 Jan; 39():218-227. PubMed ID: 26899660
[TBL] [Abstract][Full Text] [Related]
26. Role of altered arachidonic acid metabolism in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice.
Lawrence BP; Kerkvliet NI
Toxicol Sci; 1998 Mar; 42(1):13-22. PubMed ID: 9538043
[TBL] [Abstract][Full Text] [Related]
27. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte.
Dooley RK; Morris DL; Holsapple MP
Immunopharmacology; 1990; 19(1):47-58. PubMed ID: 2307581
[TBL] [Abstract][Full Text] [Related]
28. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD40 Treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity.
Shepherd DM; Steppan LB; Hedstrom OR; Kerkvliet NI
Toxicol Appl Pharmacol; 2001 Jan; 170(1):10-22. PubMed ID: 11141351
[TBL] [Abstract][Full Text] [Related]
30. Early consequences of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on the activation and survival of antigen-specific T cells.
Funatake CJ; Dearstyne EA; Steppan LB; Shepherd DM; Spanjaard ES; Marshak-Rothstein A; Kerkvliet NI
Toxicol Sci; 2004 Nov; 82(1):129-42. PubMed ID: 15310856
[TBL] [Abstract][Full Text] [Related]
31. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin promotes inflammation in mouse testes: The critical role of Klotho in Sertoli cells.
Jin M; Lou J; Yu H; Miao M; Wang G; Ai H; Huang Y; Han S; Han D; Yu G
Toxicol Lett; 2018 Oct; 295():134-143. PubMed ID: 29885354
[TBL] [Abstract][Full Text] [Related]
32. Sequestration of 2,3,7,8-tetrachlorodibenzo-p-dioxin by activated carbon eliminates bioavailability and the suppression of immune function in mice.
Boyd SA; Sallach JB; Zhang Y; Crawford R; Li H; Johnston CT; Teppen BJ; Kaminski NE
Environ Toxicol Chem; 2017 Oct; 36(10):2671-2678. PubMed ID: 28370362
[TBL] [Abstract][Full Text] [Related]
33. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
[TBL] [Abstract][Full Text] [Related]
34. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Doi H; Baba T; Tohyama C; Nohara K
Chemosphere; 2003 Jul; 52(4):655-62. PubMed ID: 12738279
[TBL] [Abstract][Full Text] [Related]
35. Search for the target genes involved in the suppression of antibody production by TCDD in C57BL/6 mice.
Nagai H; Takei T; Tohyama C; Kubo M; Abe R; Nohara K
Int Immunopharmacol; 2005 Feb; 5(2):331-43. PubMed ID: 15652763
[TBL] [Abstract][Full Text] [Related]
36. TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.
North CM; Kim BS; Snyder N; Crawford RB; Holsapple MP; Kaminski NE
Toxicol Sci; 2009 Jan; 107(1):85-92. PubMed ID: 18948302
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays.
Zeytun A; McKallip RJ; Fisher M; Camacho I; Nagarkatti M; Nagarkatti PS
Toxicology; 2002 Sep; 178(3):241-60. PubMed ID: 12167310
[TBL] [Abstract][Full Text] [Related]
38. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
39. Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity.
Fisher MT; Nagarkatti M; Nagarkatti PS
Toxicol Sci; 2004 Mar; 78(1):116-24. PubMed ID: 14718646
[TBL] [Abstract][Full Text] [Related]
40. 2,3,7,8-tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3'alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line.
Sulentic CE; Zhang W; Na YJ; Kaminski NE
J Pharmacol Exp Ther; 2004 Apr; 309(1):71-8. PubMed ID: 14718603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
